Pfizer Inc. reported sales far below Wall Street forecasts, hurt by a stronger dollar, generic competition internationally for cholesterol drug Lipitor and weak revenue in emerging markets.
*For more on this story, read the full Reuters article.
Pfizer Inc. reported sales far below Wall Street forecasts, hurt by a stronger dollar, generic competition internationally for cholesterol drug Lipitor and weak revenue in emerging markets.
*For more on this story, read the full Reuters article.
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
One-Year for Only $99